Compare QVCG & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QVCG | GALT |
|---|---|---|
| Founded | 1991 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 377.0M | 397.3M |
| IPO Year | 2026 | 2008 |
| Metric | QVCG | GALT |
|---|---|---|
| Price | $8.20 | $3.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 195.8K | 182.3K |
| Earning Date | 11-16-2026 | 11-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.84 |
| EPS | ★ 0.76 | N/A |
| Revenue | ★ $8,293,000,000.00 | N/A |
| Revenue This Year | $9.11 | N/A |
| Revenue Next Year | $55.29 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.80 | $2.03 |
| 52 Week High | $18.32 | $7.13 |
| Indicator | QVCG | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 40.25 | 39.66 |
| Support Level | $6.80 | $2.74 |
| Resistance Level | $8.59 | $3.30 |
| Average True Range (ATR) | 0.68 | 0.29 |
| MACD | 0.29 | -0.01 |
| Stochastic Oscillator | 77.78 | 19.37 |
QVC Group Inc is a live social shopping company with six retail brands: QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, and Grandin Road, and other minority interests. The group is redefining the shopping experience through video-driven commerce on every screen, from smartphones and tablets to laptops and TVs. It brings products, compelling content, and unforgettable moments to millions of shoppers world-wide.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.